We know small & large molecule bioanalysis. From first sample to final submission.
From discovery through clinical development, our scientists provide integrated bioanalytical solutions that help biotech and pharma companies move therapies forward — with scientific depth, operational flexibility, and regulatory-ready reporting built into every program.
Services
Small molecules. Biologics. One integrated bioanalytical team.
Small Molecule Services
- Method Development & Validation
- Bioanalytical testing
- DMPK & PK studies
- Formulation analysis
- Stability studies
- Regulatory support
Large Molecule / Biologics Services
- Ligand Binding Assays (LBA)
- Immunogenicity testing
- Cell & Gene therapy support
- PK/PD studies
- Biosimilar development support
Biomarker Services
Comprehensive Biomarker Capabilities
We provide end-to-end biomarker services that support translational research, clinical development, and precision medicine strategies across a wide range of therapeutic areas
01
Discovery & Translational Biomarkers
- Exploratory biomarker strategies
- Mechanism of action studies
- Translational research programs
02
Bioanalytical & Clinical Biomarkers
- PK/PD biomarker analysis
- Cytokine
- Immunogenicity assessment
- Cell-based assays
03
Genomic & Molecular Biomarkers
- qPCR and ddPCR assays
- Gene expression
04
Immunology & Flow Cytometry
- Immune cell phenotyping
- Multi-parameter flow cytometry
- Functional immune assays
- Biomarker panel development
05
Assay Development & Validation
- Custom assay development
- Fit-for-purpose validation
- GLP/GCLP-compliant workflows
- Cross-platform assay transfer
06
Therapeutic Areas
- Oncology
- Immunology & inflammation
- Rare diseases
- Infectious diseases
- Neurology
- Metabolic disorders
